GeoVax Historical Balance Sheet

GOVXW Stock

USD 0.12 0.01 9.09%

Trend analysis of GeoVax Labs balance sheet accounts such as Other Current Liabilities of 816.1 K or Total Current Liabilities of 3.7 M provides information on GeoVax Labs' total assets, liabilities, and equity, which is the actual value of GeoVax Labs to its prevalent stockholders. By breaking down trends over time using GeoVax Labs balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining GeoVax Labs latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether GeoVax Labs is a good buy for the upcoming year.

GeoVax Labs Inventory

(41,900.13)

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GeoVax Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy GeoVax Stock please use our How to Invest in GeoVax Labs guide.

About GeoVax Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of GeoVax Labs at a specified time, usually calculated after every quarter, six months, or one year. GeoVax Labs Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of GeoVax Labs and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which GeoVax currently owns. An asset can also be divided into two categories, current and non-current.

GeoVax Labs Balance Sheet Chart

At this time, GeoVax Labs' Property Plant And Equipment Gross is fairly stable compared to the past year. Property Plant Equipment is likely to climb to about 178.4 K in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 169.3 K in 2024.

Total Assets Short Long Term Debt Total Other Current Liab Accounts Payable Non Current Liabilities Total

Total Assets

Total assets refers to the total amount of GeoVax Labs assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in GeoVax Labs books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Accounts Payable

An accounting item on the balance sheet that represents GeoVax Labs obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of GeoVax Labs are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most accounts from GeoVax Labs' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into GeoVax Labs current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GeoVax Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy GeoVax Stock please use our How to Invest in GeoVax Labs guide.At this time, GeoVax Labs' Property Plant And Equipment Gross is fairly stable compared to the past year. Property Plant Equipment is likely to climb to about 178.4 K in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 169.3 K in 2024.

	2023	2024 (projected)
Short and Long Term Debt Total	178.3K	169.3K
Total Assets	9.3M	4.9M

Short Long Term Debt Total Total Assets

GeoVax Labs balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Good Will	Short Term Debt	Non Currrent Assets Other	Current Deferred Revenue	Other Assets
Total Assets		-0.09	0.65	0.69	0.97	0.91	-0.99	-0.55	0.53	0.99	0.86	0.99	-0.21	0.68	0.77	-0.07	0.59	0.66	0.66	1.0	-0.25	0.08	-0.22	0.79	0.1	-0.11
Short Long Term Debt Total	-0.09		0.02	-0.05	-0.09	-0.02	0.09	0.12	-0.12	-0.06	-0.04	-0.06	0.26	-0.11	-0.04	-0.28	-0.1	-0.12	-0.04	-0.09	0.23	0.25	0.44	-0.1	0.28	-0.28
Other Current Liab	0.65	0.02		0.86	0.49	0.55	-0.68	-0.45	0.46	0.68	0.46	0.68	-0.3	0.47	0.88	-0.24	0.3	0.47	0.91	0.66	-0.03	0.19	-0.42	0.41	0.21	-0.25
Total Current Liabilities	0.69	-0.05	0.86		0.53	0.54	-0.72	-0.82	0.85	0.69	0.65	0.69	-0.4	0.79	0.77	-0.22	0.68	0.82	0.95	0.69	-0.2	0.32	-0.46	0.66	0.23	-0.26
Total Stockholder Equity	0.97	-0.09	0.49	0.53		0.93	-0.96	-0.45	0.41	0.96	0.86	0.96	-0.14	0.6	0.64	-0.02	0.55	0.59	0.47	0.97	-0.25	0.03	-0.14	0.79	0.05	-0.06
Property Plant And Equipment Net	0.91	-0.02	0.55	0.54	0.93		-0.9	-0.42	0.38	0.9	0.88	0.9	-0.19	0.45	0.63	-0.06	0.58	0.55	0.44	0.9	-0.14	0.08	-0.12	0.84	0.06	-0.1
Net Debt	-0.99	0.09	-0.68	-0.72	-0.96	-0.9		0.57	-0.55	-0.99	-0.84	-0.99	0.19	-0.72	-0.79	0.16	-0.58	-0.69	-0.68	-0.99	0.27	-0.17	0.22	-0.78	-0.16	0.2
Retained Earnings	-0.55	0.12	-0.45	-0.82	-0.45	-0.42	0.57		-0.95	-0.52	-0.71	-0.52	0.42	-0.88	-0.35	0.28	-0.91	-0.98	-0.64	-0.52	0.23	-0.48	0.42	-0.78	-0.32	0.33
Accounts Payable	0.53	-0.12	0.46	0.85	0.41	0.38	-0.55	-0.95		0.49	0.66	0.49	-0.41	0.88	0.44	-0.12	0.87	0.94	0.7	0.51	-0.35	0.35	-0.36	0.74	0.17	-0.18
Cash	0.99	-0.06	0.68	0.69	0.96	0.9	-0.99	-0.52	0.49		0.82	1.0	-0.16	0.67	0.8	-0.15	0.52	0.63	0.67	1.0	-0.25	0.15	-0.2	0.74	0.17	-0.19
Non Current Assets Total	0.86	-0.04	0.46	0.65	0.86	0.88	-0.84	-0.71	0.66	0.82		0.82	-0.28	0.65	0.49	-0.1	0.84	0.79	0.5	0.84	-0.23	0.21	-0.21	0.97	0.18	-0.15
Cash And Short Term Investments	0.99	-0.06	0.68	0.69	0.96	0.9	-0.99	-0.52	0.49	1.0	0.82		-0.16	0.67	0.8	-0.15	0.52	0.63	0.67	1.0	-0.25	0.15	-0.2	0.74	0.17	-0.19
Net Receivables	-0.21	0.26	-0.3	-0.4	-0.14	-0.19	0.19	0.42	-0.41	-0.16	-0.28	-0.16		-0.25	-0.27	-0.34	-0.39	-0.39	-0.35	-0.2	-0.01	0.25	0.37	-0.37	0.33	-0.34
Common Stock Shares Outstanding	0.68	-0.11	0.47	0.79	0.6	0.45	-0.72	-0.88	0.88	0.67	0.65	0.67	-0.25		0.49	-0.19	0.77	0.91	0.68	0.68	-0.39	0.35	-0.38	0.68	0.21	-0.24
Non Current Liabilities Total	0.77	-0.04	0.88	0.77	0.64	0.63	-0.79	-0.35	0.44	0.8	0.49	0.8	-0.27	0.49		-0.08	0.24	0.42	0.87	0.78	-0.15	0.04	-0.16	0.42	0.08	-0.12
Inventory	-0.07	-0.28	-0.24	-0.22	-0.02	-0.06	0.16	0.28	-0.12	-0.15	-0.1	-0.15	-0.34	-0.19	-0.08		-0.06	-0.24	-0.19	-0.06	-0.06	-0.95	-0.11	-0.05	-0.96	0.99
Other Current Assets	0.59	-0.1	0.3	0.68	0.55	0.58	-0.58	-0.91	0.87	0.52	0.84	0.52	-0.39	0.77	0.24	-0.06		0.93	0.44	0.56	-0.16	0.29	-0.33	0.92	0.1	-0.11
Other Stockholder Equity	0.66	-0.12	0.47	0.82	0.59	0.55	-0.69	-0.98	0.94	0.63	0.79	0.63	-0.39	0.91	0.42	-0.24	0.93		0.64	0.64	-0.28	0.43	-0.4	0.86	0.26	-0.29
Total Liab	0.66	-0.04	0.91	0.95	0.47	0.44	-0.68	-0.64	0.7	0.67	0.5	0.67	-0.35	0.68	0.87	-0.19	0.44	0.64		0.66	-0.17	0.22	-0.38	0.46	0.22	-0.22
Total Current Assets	1.0	-0.09	0.66	0.69	0.97	0.9	-0.99	-0.52	0.51	1.0	0.84	1.0	-0.2	0.68	0.78	-0.06	0.56	0.64	0.66		-0.25	0.07	-0.22	0.77	0.09	-0.11
Common Stock	-0.25	0.23	-0.03	-0.2	-0.25	-0.14	0.27	0.23	-0.35	-0.25	-0.23	-0.25	-0.01	-0.39	-0.15	-0.06	-0.16	-0.28	-0.17	-0.25		-0.04	0.42	-0.22	0.02	-0.01
Good Will	0.08	0.25	0.19	0.32	0.03	0.08	-0.17	-0.48	0.35	0.15	0.21	0.15	0.25	0.35	0.04	-0.95	0.29	0.43	0.22	0.07	-0.04		0.06	0.21	0.93	-0.97
Short Term Debt	-0.22	0.44	-0.42	-0.46	-0.14	-0.12	0.22	0.42	-0.36	-0.2	-0.21	-0.2	0.37	-0.38	-0.16	-0.11	-0.33	-0.4	-0.38	-0.22	0.42	0.06		-0.28	0.14	-0.13
Non Currrent Assets Other	0.79	-0.1	0.41	0.66	0.79	0.84	-0.78	-0.78	0.74	0.74	0.97	0.74	-0.37	0.68	0.42	-0.05	0.92	0.86	0.46	0.77	-0.22	0.21	-0.28		0.08	-0.1
Current Deferred Revenue	0.1	0.28	0.21	0.23	0.05	0.06	-0.16	-0.32	0.17	0.17	0.18	0.17	0.33	0.21	0.08	-0.96	0.1	0.26	0.22	0.09	0.02	0.93	0.14	0.08		-0.97
Other Assets	-0.11	-0.28	-0.25	-0.26	-0.06	-0.1	0.2	0.33	-0.18	-0.19	-0.15	-0.19	-0.34	-0.24	-0.12	0.99	-0.11	-0.29	-0.22	-0.11	-0.01	-0.97	-0.13	-0.1	-0.97

Click cells to compare fundamentals

GeoVax Labs Account Relationship Matchups

GeoVax Labs balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	468.9K	10.4M	11.8M	31.3M	9.3M	4.9M
Other Current Liab	1.9M	359.3K	3.4M	3.0M	716.9K	816.1K
Total Current Liabilities	2.0M	810.3K	5.4M	4.7M	3.5M	3.7M
Total Stockholder Equity	(1.6M)	9.6M	4.4M	26.6M	5.8M	2.9M
Property Plant And Equipment Net	10.6K	159K	168K	2.4M	209.7K	391.7K
Net Debt	(243.6K)	(9.7M)	(11.4M)	(27.6M)	(6.5M)	(6.1M)
Retained Earnings	(42.8M)	(45.8M)	(64.4M)	(78.4M)	(104.4M)	(99.1M)
Accounts Payable	152.7K	267.7K	2.1M	1.7M	2.8M	2.9M
Cash	283.3K	9.9M	11.4M	27.6M	6.5M	3.3M
Non Current Assets Total	21.6K	159K	168K	2.4M	1.4M	779.5K
Cash And Short Term Investments	283.3K	9.9M	11.4M	27.6M	6.5M	3.3M
Net Receivables	121.8K	68.6K	182.7K	49.0K	44.1K	41.9K
Common Stock Shares Outstanding	5.0	10.0	201.34	2.5M	2.9M	3.1M
Liabilities And Stockholders Equity	468.9K	10.4M	11.8M	31.3M	9.3M	4.9M
Other Current Assets	95.3K	168.7K	156.2K	1.3M	1.4M	1.5M
Other Stockholder Equity	39.3M	55.3M	68.7M	105.0M	110.1M	115.6M
Total Liab	2.0M	825K	7.4M	4.7M	3.5M	2.0M
Total Current Assets	447.3K	10.2M	11.6M	28.9M	7.9M	4.1M
Common Stock	300.0	3.8K	6.4K	26.3K	2.0K	1.9K
Property Plant And Equipment Gross	10.6K	147.74	707.2K	841.4K	890.4K	934.9K
Capital Surpluse	35.6M	37.3M	39.3M	55.3M	63.6M	44.5M
Property Plant Equipment	31.2K	11.4K	10.6K	147.7K	169.9K	178.4K
Net Invested Capital	(3.5M)	9.7M	4.4M	26.6M	5.8M	6.0M
Net Working Capital	(1.6M)	9.4M	6.2M	24.2M	4.4M	6.5M
Capital Stock	1.9M	79.9K	6.4K	26.3K	2.0K	1.9K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for GeoVax Stock Analysis

When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

GeoVax Historical Balance Sheet

GeoVax Labs Inventory

(41,900.13)

About GeoVax Balance Sheet Analysis

GeoVax Labs Balance Sheet Chart

Total Assets

Accounts Payable

GeoVax Labs balance sheet Correlations

GeoVax Labs Account Relationship Matchups

High Positive Relationship

High Negative Relationship

GeoVax Labs balance sheet Accounts

Also Currently Popular

Additional Tools for GeoVax Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Cash	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Assets

Total Current Assets	- 0.99	Net Debt
Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Net Debt	- 0.99	Total Assets
Other Stockholder Equity	- 0.98	Retained Earnings
Other Assets	- 0.97	Current Deferred Revenue